Advertisement

The Latest

The U.S. Food and Drug Administration and the National Institutes of Health have announced an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients, according to an FDA news release.

8th Annual Orthopedic, Spine and Pain Management Driven ASC Conference - Special Discount Offer; June 10-12, 2010; Chicaga

Wilmington, N.C.-based TranS1, a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine, has announced that…

Advertisement